| 1 |
35246464 | Estimation of Fraction Metabolized by Cytochrome P450 Enzymes Using Long-Term Cocultured Human Hepatocytes. | 2022 May |
1 |
| 2 |
31147315 | Defining the Contribution of CYP1A1 and CYP1A2 to Drug Metabolism Using Humanized CYP1A1/1A2 and Cyp1a1/Cyp1a2 Knockout Mice. | 2019 Aug |
1 |
| 3 |
22266842 | Identification of human cytochrome P450 and flavin-containing monooxygenase enzymes involved in the metabolism of lorcaserin, a novel selective human 5-hydroxytryptamine 2C agonist. | 2012 Apr |
1 |
| 4 |
20924570 | Systemic uptake of miconazole during vaginal suppository use and effect on CYP1A2 and CYP3A4 associated enzyme activities in women. | 2010 Dec |
2 |
| 5 |
11765139 | Differential inhibition of human CYP1A1 and CYP1A2 by quinidine and quinine. | 2001 Nov |
2 |
| 6 |
10078840 | Fully automated analysis of activities catalysed by the major human liver cytochrome P450 (CYP) enzymes: assessment of human CYP inhibition potential. | 1999 Jan |
1 |
| 7 |
10418968 | Cryopreserved human hepatocytes: characterization of drug-metabolizing enzyme activities and applications in higher throughput screening assays for hepatotoxicity, metabolic stability, and drug-drug interaction potential. | 1999 Jun 1 |
1 |
| 8 |
10492058 | Effect of fluvoxamine on the pharmacokinetics of quinidine. | 1999 Aug |
1 |
| 9 |
8591723 | Multiple forms of cytochrome P450 are involved in the metabolism of ondansetron in humans. | 1995 Nov |
1 |